Complete Remission of Advanced Adrenocortical Cancer Following Mitotane Monotherapy: A Case Report and Literature Review of Predictive Markers

Mitotane has been used for the treatment of adrenocortical cancer (ACC) for over 50 years. Despite its widespread use both in monotherapy and in combination with chemotherapeutics, our knowledge of its mechanism of action and therapeutic efficacy is scarce. The number of patients with advanced ACC w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tőke, Judit, Jakab, Zsuzsanna, Stark, Júlia, Huszty, Gergely, Reismann, Péter, Tóth, Miklós
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144642/
https://www.ncbi.nlm.nih.gov/pubmed/34046364
http://dx.doi.org/10.3389/fonc.2021.680853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144642/
https://www.ncbi.nlm.nih.gov/pubmed/34046364
http://dx.doi.org/10.3389/fonc.2021.680853

Ejemplares similares